Дезлоратадин (Эриус) при лечении кожной патологии, сопровождающейся уртикарными высыпаниями у детей
И. М. Корсунская, Т. В. Шашкова · CyberLeninK (CyberLeninka) · 2003
The authors have carried out a clinical trial of new antiallergic and anti-inflammatory drug desloratadine (Aerius) in eighteen 12-to-17-year-old children suffering from relapsing urticaria and atopic dermatitis. The appearance of new eruptions was noted to discontinue on days 3-10, and itching was seen to disappear on days 4-7. The patients' quality of life was noted to improve. Neither drug's intolerance, nor adverse reaction were observed.
Cited by 0 works.